- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2015
- Public Summary Document (PSD) March 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2015 PBAC Meeting - Word
Rituximab – March 2015
Rituximab; 500 mg/50 mL injection: 1 x 50 mL vial; MabThera®
Last updated
17 July 2015